Aspirin Primary Prevention Benefit in Those With Raised Lp(a)? Aspirin Primary Prevention Benefit in Those With Raised Lp(a)?

A new analysis of the ASPREE primary prevention trial of aspirin has shown a net clinical benefit in those with genotypes associated with raised levels of Lp(a), results which validate similar findings in the Women ' s Health Study.Medscape Medical News

Source: Medscape Cardiology Headlines - September 28, 2022 Category: Cardiology Tags: Cardiology News Source Type: news